نویسندگان | Goshtasbi H. - Abdolahinia E.D. - Fathi M. - Movafeghi A. - Omidian H. - Barar J. - Omidi Y |
---|---|
نشریه | Journal of Microencapsulation |
ارائه به نام دانشگاه | University of Tabriz |
شماره صفحات | 140–156 |
شماره سریال | 41 |
شماره مجلد | 2 |
ضریب تاثیر (IF) | 3.9 |
نوع مقاله | Full Paper |
تاریخ انتشار | 2024-05-01 |
رتبه نشریه | ISI (WOS) |
نوع نشریه | چاپی |
کشور محل چاپ | بریتانیا |
نمایه نشریه | JCR, SCImago (SJR), Scopus |
چکیده مقاله
Oxidative stress (OS) plays a crucial role in disease development. Astaxanthin (ATX), a valuable natural compound, may reduce OS and serve as a treatment for diseases like neurodegenerative disorders and cancer. Nuclear factor-erythroid 2-related factor 2 (Nrf2) regulates antioxidant enzymes and OS management. We evaluated ATX’s antioxidant activity via Alg-CS/ATX gel beads in vitro. ATX-encapsulated alginate-chitosan (Alg-CS/ATX) gel beads were synthesized and structurally/morphologically characterized by SEM, FT-IR, and XRD. Their biological effects were examined in human umbilical vein endothelial cells (HUVECs) treated with H2O2 through MTT assay, Annexin V/PI, cell cycle studies, and western blotting. Alg-CS effectively carried ATX, with high capacity and reduced pore size. Alg-CS/ATX displayed an 84% encapsulation efficiency, maintaining stability for 30 days. In vitro studies showed a 1.4-fold faster release at pH 5.4 than at neutral pH, improving ATX’s therapeutic potential. HUVECs treated with Alg-CS/ATX showed enhanced viability via increased Nrf2 expression. Alg-CS gel beads exhibit significant potential as a biocompatible vehicle for delivering ATX to combat OS with considerable opportunity for clinical applications.